81 related articles for article (PubMed ID: 7657323)
1. [The inhibitory effect of intraperitoneal hyperthermic and hypotonic chemotherapy on ascites cancer cells in mice].
Chen Z; Peng D; Tan J
Hua Xi Yi Ke Da Xue Xue Bao; 1995 Mar; 26(1):101-4. PubMed ID: 7657323
[TBL] [Abstract][Full Text] [Related]
2. Treatment of cancerous ascites and radical gastrectomy with intraperitoneal hyperthermic double-distilled water and cis-diaminodichloro-platinum perfusion.
Chen ZX; Chen JP; Chen Z; Peng DS; Zhen JX; Tan JS
World J Gastroenterol; 1997 Dec; 3(4):246-8. PubMed ID: 27053879
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of hypotonic cisplatin chemotherapy administered into the peritoneal and the pleural cavities in experimental model.
Katano K; Tsujitani S; Oka S; Saito H; Gomyo Y; Kondo A; Ikeguchi M; Maeta M; Kaibara N
Anticancer Res; 2000; 20(3A):1603-7. PubMed ID: 10928078
[TBL] [Abstract][Full Text] [Related]
4. Hypotonic intrapleural cisplatin chemotherapy as treatment for pleural carcinomatosis in an experimental model.
Katano K; Tsujitani S; Saito H; Ikeguchi M; Maeta M; Kaibara N
Anticancer Res; 1997; 17(6D):4547-52. PubMed ID: 9494566
[TBL] [Abstract][Full Text] [Related]
5. Hypotonic intraperitoneal cisplatin chemotherapy for peritoneal carcinomatosis in mice.
Kondo A; Maeta M; Oka A; Tsujitani S; Ikeguchi M; Kaibara N
Br J Cancer; 1996 May; 73(10):1166-70. PubMed ID: 8630273
[TBL] [Abstract][Full Text] [Related]
6. Synergism between propolis and hyperthermal intraperitoneal chemotherapy with cisplatin on ehrlich ascites tumor in mice.
Oršolić N; Car N; Lisičić D; Benković V; Knežević AH; Dikić D; Petrik J
J Pharm Sci; 2013 Dec; 102(12):4395-405. PubMed ID: 24136132
[TBL] [Abstract][Full Text] [Related]
7. Administration in a hypotonic solution is preferable to dose escalation in intraperitoneal cisplatin chemotherapy for peritoneal carcinomatosis in rats.
Tsujitani S; Oka A; Kondo A; Katano K; Oka S; Saito H; Ikeguchi M; Maeta M; Kaibara N
Oncology; 1999 Jul; 57(1):77-82. PubMed ID: 10394129
[TBL] [Abstract][Full Text] [Related]
8. Simulation of Chemoperfusion Treatment for Abdominal Carcinomatosis.
Bespalov VG; Belyaeva OA; Kireeva GS; Senchik KY; Stukov AN; Belyaev AM
Bull Exp Biol Med; 2015 May; 159(1):81-4. PubMed ID: 26033596
[TBL] [Abstract][Full Text] [Related]
9. Fibrin-sealant-delivered cisplatin chemotherapy versus cisplatin hyperthermic intraperitoneal perfusion chemotherapy for locally advanced gastric cancer without peritoneal metastases: a randomized phase-II clinical trial with a 40-month follow-up.
Huang O; Lu X; Xu X; Shi Y
Cell Biochem Biophys; 2015 Mar; 71(2):1171-80. PubMed ID: 25398590
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy of intraoperative hypotonic peritoneal chemo-hyperthermia combined with early postoperative intraperitoneal chemotherapy on gastric cancer].
Wei G; Fang GE; Bi JW; Shen XJ; Nie MM; Xue XC; Hua JD
Ai Zheng; 2005 Apr; 24(4):478-82. PubMed ID: 15820074
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and pharmacodynamics of cisplatin after intraoperative hyperthermic intraperitoneal chemoperfusion (HIPEC).
Zeamari S; Floot B; van der Vange N; Stewart FA
Anticancer Res; 2003; 23(2B):1643-8. PubMed ID: 12820435
[TBL] [Abstract][Full Text] [Related]
12. [A case of malignant peritoneal mesothelioma successfully treated with hyperthermic chemotherapy].
Shinoki N; Fukuda I; Kinuta M; Yamamoto H; Fujimura H; Nishizawa Y; Fujitani K; Seki K; Tateishi R
Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1676-8. PubMed ID: 1530329
[TBL] [Abstract][Full Text] [Related]
13. Experimental hyperthermic isolation-perfusion using cis-diamminedichloroplatinum(II).
Wile AG; Nahabedian MY; Plumley DA; Guilmette JE; Mason GR
Cancer Res; 1983 Jul; 43(7):3108-11. PubMed ID: 6682699
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of intraperitoneal hyperthermic perfusion with mitoxantrone in ovarian cancer.
Nicoletto MO; Padrini R; Galeotti F; Ferrazzi E; Cartei G; Riddi F; Palumbo M; De Paoli M; Corsini A
Cancer Chemother Pharmacol; 2000; 45(6):457-62. PubMed ID: 10854132
[TBL] [Abstract][Full Text] [Related]
15. Histological response of peritoneal carcinomatosis after hyperthermic intraperitoneal chemoperfusion (HIPEC) in experimental investigations.
Pelz JO; Doerfer J; Dimmler A; Hohenberger W; Meyer T
BMC Cancer; 2006 Jun; 6():162. PubMed ID: 16792796
[TBL] [Abstract][Full Text] [Related]
16. Laparoscopic intraperitoneal hyperthermic chemotherapy for palliation of debilitating malignant ascites.
Garofalo A; Valle M; Garcia J; Sugarbaker PH
Eur J Surg Oncol; 2006 Aug; 32(6):682-5. PubMed ID: 16631341
[TBL] [Abstract][Full Text] [Related]
17. A new survival model for hyperthermic intraperitoneal chemotherapy (HIPEC) in tumor-bearing rats in the treatment of peritoneal carcinomatosis.
Pelz JO; Doerfer J; Hohenberger W; Meyer T
BMC Cancer; 2005 May; 5():56. PubMed ID: 15924622
[TBL] [Abstract][Full Text] [Related]
18. [Telomerase antisense inhibition and chemotherapeutic combination treatments for the proliferation of endometrial cancer in vitro and in vivo].
Chen XJ; Zheng W; Chen LL; Chen ZB; Wang SQ
Zhonghua Yi Xue Za Zhi; 2004 Oct; 84(20):1721-5. PubMed ID: 15569435
[TBL] [Abstract][Full Text] [Related]
19. Anesthesia considerations during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Rothfield KP; Crowley K
Surg Oncol Clin N Am; 2012 Oct; 21(4):533-41. PubMed ID: 23021714
[TBL] [Abstract][Full Text] [Related]
20. [Cell division reaction in mouse Ehrlich ascites tumor in response to adrenaline].
Romanov IuA; Biks KA
Biull Eksp Biol Med; 1981; 91(1):69-71. PubMed ID: 7214012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
